Literature DB >> 9724905

Formulation and in vitro evaluation of ibuprofen-Carbopol 974P-NF controlled release matrix tablets. III: Influence of co-excipients on release rate of the drug.

G M Khan1, Z Jiabi.   

Abstract

In order to assess the potential of carbopol 974P-NF as matrix material in hydrophilic matrix tablets containing a slightly water-soluble drug, ibuprofen (IBF), controlled release matrix tablets of ibuprofen and carbopol 974P-NF, at different drug to polymer ratios, were prepared by the direct compression method. The influence of the concentration of the matrix material (carbopol 974P) and several co-excipients (lactose, microcrystalline cellulose, and starch) on the release rate of the drug was investigated. An in vitro dissolution test in pH 7.2 phosphate buffer solution showed that drug release from all the formulations containing carbopol 974P was considerably prolonged in concentration-dependent manners. Increasing the amount of carbopol 974P in tablets resulted in a reduction in the drug release rate and a linearization of the drug release curve. When the influence of the co-excipients on the release of the drug was examined, all of the co-excipients used in this study enhanced the release rate of IBF. However, lactose demonstrated slower and more linear release behavior as compared in microcrystalline cellulose or starch. The dissolution T50 and T90 values for the three co-excipients were in the order of lactose > microcrystalline cellulose > starch.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9724905     DOI: 10.1016/s0168-3659(97)00225-3

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  14 in total

1.  Study on of bioadhesive property of carbomer 934 by a gamma camera in vivo.

Authors:  Jie Fu; Xun Sun; Zhi-Rong Zhang
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

2.  Formulation variables influencing drug release from layered matrix system comprising chitosan and xanthan gum.

Authors:  Thawatchai Phaechamud; Garnpimol C Ritthidej
Journal:  AAPS PharmSciTech       Date:  2008-07-25       Impact factor: 3.246

3.  Effect of Kollidon® SR on the release of Albuterol Sulphate from matrix tablets.

Authors:  Walid Sakr; Fars Alanazi; Adel Sakr
Journal:  Saudi Pharm J       Date:  2010-11-04       Impact factor: 4.330

Review 4.  Physiologically-based pharmacokinetic models: approaches for enabling personalized medicine.

Authors:  Clara Hartmanshenn; Megerle Scherholz; Ioannis P Androulakis
Journal:  J Pharmacokinet Pharmacodyn       Date:  2016-09-19       Impact factor: 2.745

5.  Application of pharmaceutical QbD for enhancement of the solubility and dissolution of a class II BCS drug using polymeric surfactants and crystallization inhibitors: development of controlled-release tablets.

Authors:  Emad B Basalious; Wessam El-Sebaie; Omaima El-Gazayerly
Journal:  AAPS PharmSciTech       Date:  2011-06-24       Impact factor: 3.246

6.  Development and evaluation of oral multiple-unit and single-unit hydrophilic controlled-release systems.

Authors:  M Efentakis; A Koutlis; M Vlachou
Journal:  AAPS PharmSciTech       Date:  2000-12-01       Impact factor: 3.246

7.  In vitro release dynamics of model drugs from psyllium and acrylic acid based hydrogels for the use in colon specific drug delivery.

Authors:  Baljit Singh; Ritu Bala; Nirmala Chauhan
Journal:  J Mater Sci Mater Med       Date:  2008-02-29       Impact factor: 3.896

8.  Optimization of Salbutamol Sulfate Dissolution from Sustained Release Matrix Formulations Using an Artificial Neural Network.

Authors:  Faith Chaibva; Michael Burton; Roderick B Walker
Journal:  Pharmaceutics       Date:  2010-05-06       Impact factor: 6.321

9.  Bucco-Adhesive Film as a Pediatric Proper Dosage Form for Systemic Delivery of Propranolol Hydrochloride: In-vitro and in-vivo Evaluation.

Authors:  Soad A Mohamad; Hesham Salem; Heba A Yassin; Heba F Mansour
Journal:  Drug Des Devel Ther       Date:  2020-10-15       Impact factor: 4.162

10.  Formulation and in vitro, in vivo evaluation of effervescent floating sustained-release imatinib mesylate tablet.

Authors:  Ali Kadivar; Behnam Kamalidehghan; Hamid Akbari Javar; Ehsan Taghizadeh Davoudi; Nurul Dhania Zaharuddin; Bahareh Sabeti; Lip Yong Chung; Mohamed Ibrahim Noordin
Journal:  PLoS One       Date:  2015-06-02       Impact factor: 3.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.